Thyroid Disease in the Pregnancy and Congenital Malformations of Newborns

Česká verzia

Authors: V. Vargová ¹; V. Mechírová ²; M. Pytliak ³; M. Tajtáková ²
Authors place of work: III. interná klinika FN LP a UP JŠ, Košice, prednosta doc. MUDr. P. Mitro, PhD. ¹; I. interná klinika FN LP a UP JŠ, Košice ²; Ústav pre bakalárske a magisterské štúdiá, LF UP JŠ, Košice ³
Published in the journal: Ceska Gynekol 2008; 73(1): 35-40

Summary

The aim:
The aim of this study was to compare thyroidal status of mothers who delivered newborns with morphological congenital malformations and mothers with healthy newborns.

Type of the study:
One-time cross-sectional study.

Setting:
3rd internal clinic FN LP, Košice.

Methods:
We examined 43 mothers with newborns born with congenital malformation and 76 mothers with healthy newborns. The protocol included anamnesis, basic physical examination, ultrasonography of the thyroid, assessment of the mothers’ plasma fT₄, TSH and anti-TPO levels, and comparison of the birth weight and birth length of the newborns. The results were statistically processed by PC programs StatsDirect 2.6.2 and MS Excel 2000.

Results:
The thyroid volume was significantly greater in mothers with newborns with congenital malformation as in the control group (p<0.001). The birth weight and birth length was significantly lower in newborns with malformations (p<0.0001 resp. p<0.001). We found no differences in the plasma levels of fT₄, TSH and anti-TPO between these groups.

Conclusion:
Thyroid disease of the mother can contribute to the congenital malformations of the newborn although there was found no direct association between mothers’ thyroid autoantibodies and creation of congenital malformations of the child, yet.

Key words:
thyroid, congenital malformations, autoantibodies

Zdroje

1. Abalovich, M., Gutierrez, S., Alcaraz, G., et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid, 2002, 12, p. 63-68.

2. Dankovčík, R., Ostró, A., Grešová, A. Štrukturálne a chromozómové abnormality ľudského plodu. 80. výročie založenia Fakultnej nemocnice Louisa Pasteura : Košice, 14. október 2004 : zborník referátov, 2004. S. 128-130.

3. Galambos, C., Brink, DS., Chung, HD. Thyroid function during pregnancy. Clin Chem, 2000, 46, 7, p. 1115-1117.

4. Haddow, JE., Polomaki, GE., Allan, WC., et al. Mathernal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med, 1999, 341, p. 549-555.

5. Herhman, JM. Human choriongonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors. Thyroid, 1999, 9, p. 653-657.

6. Keisner, E., Neto, EC., Gross, JL. High prevalence of extrathyroid malformations in cohort of Brasilian patients with permanent primary congenital hypothyroidism. Thyroid, 2005, 15, 2, p. 165-169.

7. Kim, CH., Chae, HD., et al. Influence of antithyroid antibodies in euthyroid women on in vitro fertilisation-embryo transfer outcome. Am J Reprod Immunol, 2000, 40, p. 2-8.

8. Krassas, GE. Thyroid disease and female reproduction. Fertil Steril, 2000, 74, p. 1063-1070.

9. Lazár, I., Ostró, A., Dankovčík, R., et al. Skríning tyreopatií v I. trimestri gravidity. Reprodukčná medicína : zborník z vedeckej konferencie s medzinárodnou účasťou pri príležitosti 10. výročia založenia Centra asistovanej reprodukcie pri II. gynekologicko-pôrodníckej klinike LF UPJŠ a FN L. Pasteura / Editori: R. Hredzák, A. Ostró, J. Kačmárik, 2005. S. 87-88.

10. Mandel, SJ., Cooper, DS. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab, 2001, 86, 6, p. 2354-2359.

11. Masiukiewicz, US., Burrow, GN. Hyperthyroidism in pregnancy: diagnosis and treatment. Thyroid, 1999, 9, p. 647-652.

12. Momotani, N., Noh, JY., Ishikawa, N., Ito, K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves@ hyperthyroidism. J Clin Endocrinol Metab, 1997, 82, p. 3633-3636.

13. Ramirez, A., Espinosa de los Monteros, A., Parra, A., De Leon, B. Esophageal atresia and tracheoesophageal fistula in two infants born to hyperthyroid women receiving methimazole (Tapazol®) during pregnancy. Am J Med Genet, 1992, 44, 2, p. 200-202.

14. Roti, E., Minelli, R., Salvio, M. Management of hyperthyroidism and hypothyroidism in the pregnant woman. J Clin Endocrinol Metab, 1996, 81, p. 1679-1683.

15. Shahid, R. Pregnancy with hyperthyroidism. J Coll Physicians Surg Pak, 2003, 13, 5, p. 255-259.

16. Siman, CM., Gittenberger-De Groot, AC., Wisse, B., Eriksson, UJ. Malformations in offspring of diabetic rats: morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment. Teratology, 2000, 61, p. 355-367.

17. Stagnaro-Green, A., Chen, X., Bogden, JD., et al. The thyroid and pregnancy: A novel risk factor for very preterm delivery. Thyroid, 2005, 15, 4, p. 351-357.

18. Stagnaro-Green, A. Postpartum thyroiditis: prevalence, etiology and clinical implications. Thyroid Today, 1993, 16, p. 1-11.

19. Stagnaro-Green, AS., Roman, SH., et al. A prospective study of lymphocyte-initiated immunosuppresion in normal pregnancy: Evidence of T-cell etiology for postpartum thyroid dysfunction. J Clin Endocrinol Metab, 1992, 74, p. 645-653.

20. Tajtáková, M., Petrovičová, J., Langer, P., et al. Štítna žľaza u žien v reprodukčnom veku. Čes Gynek, 2003, 68, 5, s. 306-310.

21. Wolfberg, D., Nagey, A. Thyroid disease during pregnancy and subsequent congenital anomalies. Thyroid, 2002, 125, p. 274-278.

22. Xue-Yi, C., Xin-Min, J., Zhi Hong, D., et al. Timing of vulnerability of the brain to iodine deficiency in endemic cretenism. N Engl J Med, 1994, 221, p. 1739-744.